About 4-butoxy-N-[2-(dimethylamino)-2-phenylethyl]-3,5-dimethylbenzamide;4-butoxy-N-[(4-hydroxy-1-methylpiperidin-4-yl)methyl]-3,5-dimethylbenzamide;N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[2-(dimethylamino)-2-phenylethyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[(1-hydroxycyclohexyl)methyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[(4-hydroxy-1-methylpiperidin-4-yl)methyl]-3,5-dimethyl-4-phenylmethoxybenzamide
4-butoxy-N-[2-(dimethylamino)-2-phenylethyl]-3,5-dimethylbenzamide;4-butoxy-N-[(4-hydroxy-1-methylpiperidin-4-yl)methyl]-3,5-dimethylbenzamide;N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[2-(dimethylamino)-2-phenylethyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[(1-hydroxycyclohexyl)methyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[(4-hydroxy-1-methylpiperidin-4-yl)methyl]-3,5-dimethyl-4-phenylmethoxybenzamide (PubChem CID 160648014) has the molecular formula C140H185F2N11O15
and a molecular weight of 2300.08 g/mol. Its IUPAC name is 4-butoxy-N-[2-(dimethylamino)-2-phenylethyl]-3,5-dimethylbenzamide;4-butoxy-N-[(4-hydroxy-1-methylpiperidin-4-yl)methyl]-3,5-dimethylbenzamide;N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[2-(dimethylamino)-2-phenylethyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[(1-hydroxycyclohexyl)methyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[(4-hydroxy-1-methylpiperidin-4-yl)methyl]-3,5-dimethyl-4-phenylmethoxybenzamide.
Frequently Asked Questions
What is the IUPAC name of 4-butoxy-N-[2-(dimethylamino)-2-phenylethyl]-3,5-dimethylbenzamide;4-butoxy-N-[(4-hydroxy-1-methylpiperidin-4-yl)methyl]-3,5-dimethylbenzamide;N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[2-(dimethylamino)-2-phenylethyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[(1-hydroxycyclohexyl)methyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[(4-hydroxy-1-methylpiperidin-4-yl)methyl]-3,5-dimethyl-4-phenylmethoxybenzamide?
The IUPAC name of 4-butoxy-N-[2-(dimethylamino)-2-phenylethyl]-3,5-dimethylbenzamide;4-butoxy-N-[(4-hydroxy-1-methylpiperidin-4-yl)methyl]-3,5-dimethylbenzamide;N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[2-(dimethylamino)-2-phenylethyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[(1-hydroxycyclohexyl)methyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[(4-hydroxy-1-methylpiperidin-4-yl)methyl]-3,5-dimethyl-4-phenylmethoxybenzamide (CID 160648014) is 4-butoxy-N-[2-(dimethylamino)-2-phenylethyl]-3,5-dimethylbenzamide;4-butoxy-N-[(4-hydroxy-1-methylpiperidin-4-yl)methyl]-3,5-dimethylbenzamide;N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[2-(dimethylamino)-2-phenylethyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[(1-hydroxycyclohexyl)methyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[(4-hydroxy-1-methylpiperidin-4-yl)methyl]-3,5-dimethyl-4-phenylmethoxybenzamide.
What is the SMILES notation for 4-butoxy-N-[2-(dimethylamino)-2-phenylethyl]-3,5-dimethylbenzamide;4-butoxy-N-[(4-hydroxy-1-methylpiperidin-4-yl)methyl]-3,5-dimethylbenzamide;N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[2-(dimethylamino)-2-phenylethyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[(1-hydroxycyclohexyl)methyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[(4-hydroxy-1-methylpiperidin-4-yl)methyl]-3,5-dimethyl-4-phenylmethoxybenzamide?
The canonical SMILES for 4-butoxy-N-[2-(dimethylamino)-2-phenylethyl]-3,5-dimethylbenzamide;4-butoxy-N-[(4-hydroxy-1-methylpiperidin-4-yl)methyl]-3,5-dimethylbenzamide;N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[2-(dimethylamino)-2-phenylethyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[(1-hydroxycyclohexyl)methyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[(4-hydroxy-1-methylpiperidin-4-yl)methyl]-3,5-dimethyl-4-phenylmethoxybenzamide is CCCCOc1c(C)cc(C(=O)NCC(c2ccccc2)N(C)C)cc1C.CCCCOc1c(C)cc(C(=O)NCC2(O)CCN(C)CC2)cc1C.Cc1cc(C(=O)NCC(c2ccccc2)N(C)C)cc(C)c1OCc1ccccc1.Cc1cc(C(=O)NCC2(N(C)C)CCC(F)(F)CC2)cc(C)c1OCc1ccccc1.Cc1cc(C(=O)NCC2(O)CCCCC2)cc(C)c1OCc1ccccc1.Cc1cc(C(=O)NCC2(O)CCN(C)CC2)cc(C)c1OCc1ccccc1.
What is the InChIKey of 4-butoxy-N-[2-(dimethylamino)-2-phenylethyl]-3,5-dimethylbenzamide;4-butoxy-N-[(4-hydroxy-1-methylpiperidin-4-yl)methyl]-3,5-dimethylbenzamide;N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[2-(dimethylamino)-2-phenylethyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[(1-hydroxycyclohexyl)methyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[(4-hydroxy-1-methylpiperidin-4-yl)methyl]-3,5-dimethyl-4-phenylmethoxybenzamide?
The InChIKey is RKAWANQKKAIPCR-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H30N2O2.C25H32F2N2O2.C23H30N2O3.C23H32N2O2.C23H29NO3.C20H32N2O3/c1-19-15-23(16-20(2)25(19)30-18-21-11-7-5-8-12-21)26(29)27-17-24(28(3)4)22-13-9-6-10-14-22;1-18-14-21(15-19(2)22(18)31-16-20-8-6-5-7-9-20)23(30)28-17-24(29(3)4)10-12-25(26,27)13-11-24;1-17-13-20(22(26)24-16-23(27)9-11-25(3)12-10-23)14-18(2)21(17)28-15-19-7-5-4-6-8-19;1-6-7-13-27-22-17(2)14-20(15-18(22)3)23(26)24-16-21(25(4)5)19-11-9-8-10-12-19;1-17-13-20(22(25)24-16-23(26)11-7-4-8-12-23)14-18(2)21(17)27-15-19-9-5-3-6-10-19;1-5-6-11-25-18-15(2)12-17(13-16(18)3)19(23)21-14-20(24)7-9-22(4)10-8-20/h5-16,24H,17-18H2,1-4H3,(H,27,29);5-9,14-15H,10-13,16-17H2,1-4H3,(H,28,30);4-8,13-14,27H,9-12,15-16H2,1-3H3,(H,24,26);8-12,14-15,21H,6-7,13,16H2,1-5H3,(H,24,26);3,5-6,9-10,13-14,26H,4,7-8,11-12,15-16H2,1-2H3,(H,24,25);12-13,24H,5-11,14H2,1-4H3,(H,21,23).
What are the key properties of 4-butoxy-N-[2-(dimethylamino)-2-phenylethyl]-3,5-dimethylbenzamide;4-butoxy-N-[(4-hydroxy-1-methylpiperidin-4-yl)methyl]-3,5-dimethylbenzamide;N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[2-(dimethylamino)-2-phenylethyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[(1-hydroxycyclohexyl)methyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[(4-hydroxy-1-methylpiperidin-4-yl)methyl]-3,5-dimethyl-4-phenylmethoxybenzamide?
4-butoxy-N-[2-(dimethylamino)-2-phenylethyl]-3,5-dimethylbenzamide;4-butoxy-N-[(4-hydroxy-1-methylpiperidin-4-yl)methyl]-3,5-dimethylbenzamide;N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[2-(dimethylamino)-2-phenylethyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[(1-hydroxycyclohexyl)methyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[(4-hydroxy-1-methylpiperidin-4-yl)methyl]-3,5-dimethyl-4-phenylmethoxybenzamide has a molecular weight of 2300.08 g/mol, XLogP of 24.60, 43 rotatable bonds, 9 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 4-butoxy-N-[2-(dimethylamino)-2-phenylethyl]-3,5-dimethylbenzamide;4-butoxy-N-[(4-hydroxy-1-methylpiperidin-4-yl)methyl]-3,5-dimethylbenzamide;N-[[1-(dimethylamino)-4,4-difluorocyclohexyl]methyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[2-(dimethylamino)-2-phenylethyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[(1-hydroxycyclohexyl)methyl]-3,5-dimethyl-4-phenylmethoxybenzamide;N-[(4-hydroxy-1-methylpiperidin-4-yl)methyl]-3,5-dimethyl-4-phenylmethoxybenzamide is sourced from PubChem (CID 160648014), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).